Most patients with mild COVID-19 infections produce antibodies that persist and protect them from reinfection for up to six months, a new study found. The antibodies' ability to neutralize COVID-19 did not differ significantly from the first visit, which occurred three months after infection, to the second visit at the six-month mark.
from Latest Science News -- ScienceDaily https://ift.tt/3tEq7zY
via IFTTT
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment